Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Andres O. Soriano, MD, Richard Champlin, MD, Gloria McCormick, Sergio Giralt, MD, Peter Thall, PhD, Krishna Komanduri, MD, Muzaffar Qazilbash, MD, Guillermo Garcia-Manero, MD, Marcos De Lima, MD

Blood (2006) 108 (11): 3668.

https://doi.org/10.1182/blood.V108.11.3668.3668

Published: 2006

Journal Articles

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Andres O. Soriano, MD, Hui Yang, MD, Weigang Tong, MD, Stefan Faderl, MD, William Wierda, MD, Michael Andreeff, MD, Zeev Estrov, MD, Souzanne Ouzounian, MD, Jonathan Clavell, Hagop Kantarjian, MD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD

Blood (2006) 108 (11): 160.

https://doi.org/10.1182/blood.V108.11.160.160

Published: 2006

Journal Articles

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

Andres O. Soriano, MD, Michael Thompson, MD, Jorge Romaguera, MD, Alma Rodriguez, MD, Fredrick B. Hagemeister, MD, Luis Fayad, MD, Joan H. Admirand, MD, Barbara Pro, MD

Blood (2005) 106 (11): 3892.

https://doi.org/10.1182/blood.V106.11.3892.3892

Published: 2005

Journal Articles

CD62E-Positive Endothelial Microparticle-Neutrophil Conjugates, a Novel Marker of Prothrombotic and Inflammatory Disorders.

Julio A. Chirinos, MD, Wenche Jy, PhD, Andres O. Soriano, MD, Aurelio Castrellon, MD, Freddy Del Carpio, MD, Roque Arteaga, MD, Gustavo A. Heresi, MD, Joaquin J. Jimenez, MD, Lawrence L. Horstman, BS, Yeon S. Ahn, MD

Blood (2005) 106 (11): 3958.

https://doi.org/10.1182/blood.V106.11.3958.3958

Published: 2005

Journal Articles

Platelet Binding to Leukocytes as a Determinant of Leukocyte Activation In Vivo .

Julio A. Chirinos, MD, Wenche Jy, PhD, Maike Tiede, MD, Aurelio Castrellon, MD, Andres O. Soriano, MD, Freddy Del Carpio, MD, Roque Arteaga, MD, Joaquin J. Jimenez, MD, Lawrence Horstman, BS, Carlos Bidot, MD, Yeon S. Ahn, MD

Blood (2005) 106 (11): 3862.

https://doi.org/10.1182/blood.V106.11.3862.3862

Published: 2005

Journal Articles

Endothelial Microparticles (EMP) Expressing CD31 but Not CD62E Correlate with Improved Survival in Severe Sepsis.

Andres O. Soriano, MD, Julio A. Chirinos, MD, Wenche Jy, PhD, Lawrence L. Horstman, BS, Martin A. Valdivia, MD, Hermes S. Velasquez, MD, Yeon S. Ahn, MD

Blood (2004) 104 (11): 2625.

https://doi.org/10.1182/blood.V104.11.2625.2625

Published: 2004

Journal Articles

Levels of GP-Iib/Iiia Positive Platelet Microparticles (PMP) but Not CD31+/CD42+ PMP Predict Adverse Outcomes in Troponin-Negative Patients with Chest Pain.

Julio A. Chirinos, MD, Hermes Velazquez, MD, Mariana Canoniero, MD, Andres O. Soriano, MD, Leon Bernal-Mizrachi, MD, Wenche Jy, PhD, Lawrence L. Horstman, MS, Joaquin J. Jimenez, MD, Eduardo De Marchena, MD, Alex Ferreira, MD, Yeon S. Ahn, MD

Blood (2004) 104 (11): 2583.

https://doi.org/10.1182/blood.V104.11.2583.2583

Published: 2004

NARROW

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

CD62E-Positive Endothelial Microparticle-Neutrophil Conjugates, a Novel Marker of Prothrombotic and Inflammatory Disorders.

Platelet Binding to Leukocytes as a Determinant of Leukocyte Activation In Vivo .

Endothelial Microparticles (EMP) Expressing CD31 but Not CD62E Correlate with Improved Survival in Severe Sepsis.

Levels of GP-Iib/Iiia Positive Platelet Microparticles (PMP) but Not CD31+/CD42+ PMP Predict Adverse Outcomes in Troponin-Negative Patients with Chest Pain.

Email alerts

ASH Publications

American Society of Hematology

Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

CD62E-Positive Endothelial Microparticle-Neutrophil Conjugates, a Novel Marker of Prothrombotic and Inflammatory Disorders.

Platelet Binding to Leukocytes as a Determinant of Leukocyte Activation In Vivo .

Endothelial Microparticles (EMP) Expressing CD31 but Not CD62E Correlate with Improved Survival in Severe Sepsis.

Levels of GP-Iib/Iiia Positive Platelet Microparticles (PMP) but Not CD31+/CD42+ PMP Predict Adverse Outcomes in Troponin-Negative Patients with Chest Pain.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only